Family burden, quality of life and disability in obsessive compulsive disorder: An Indian perspective
GP Gururaj, S Bada Math, JYC Reddy, CR Chandrashekar
OCD Clinic, Department of Psychiatry, National Institute of Mental Health and Neuro Sciences, Bangalore- 560 029, India
S Bada Math
OCD Clinic, Department of Psychiatry, National Institute of Mental Health and Neuro Sciences, Bangalore- 560 029
Background: Obsessive compulsive disorder (OCD) is a psychiatric disorder that often tends to run a chronic course. The lifetime prevalence of OCD is around 1-3%, which is twice as prevalent as schizophrenia and bipolar disorder. Aim: To asses the family burden, quality of life (QoL) and disability in patients suffering from at least moderately ill OCD and then to compare them with schizophrenia patients of comparable severity. Settings and Design: We recruited 70 consecutive subjects (OCD=35, schizophrenia=35) who met study criteria between March 2005 and March 2006 from the psychiatric services of the National Institute of Mental Health and Neuro Sciences, Bangalore, India. Materials and Methods: The severity of illness was rated using the Clinical Global Impression-Severity (CGI-S). Instruments used in the current study were the Family Burden Schedule, the World Health Organization (WHO) QoL (Bref) and the WHO - Disability Assessment Schedule (DAS). Statistical Analysis: The Fisher«SQ»s exact test/chi-square test was used to compare categorical variables and the independent sample t test was used to analyze continuous variables. Analysis of covariance (ANCOVA) was used to compare the groups after controlling for potential confounding variables. Pearson«SQ»s correlation was used for correlation analysis. Results: Overall family burden, financial burden and disruption of family routines were significantly higher in schizophrenia patients compared to OCD although the groups did not differ with respect to other domains of family burden. On the WHO QoL, OCD patients were comparable to schizophrenia patients with respect to the psychological and social domains. On the WHO - DAS, both the groups were similar in all the domains except getting around. Conclusion: Severe OCD is associated with significant disability, poor QoL and high family burden, often comparable to schizophrenia. Therefore, there is an urgent need to increase the sensitivity among healthcare professionals to recognize and treat OCD.
|How to cite this article:|
Gururaj G P, Math S B, Reddy J, Chandrashekar C R. Family burden, quality of life and disability in obsessive compulsive disorder: An Indian perspective.J Postgrad Med 2008;54:91-97
|How to cite this URL:|
Gururaj G P, Math S B, Reddy J, Chandrashekar C R. Family burden, quality of life and disability in obsessive compulsive disorder: An Indian perspective. J Postgrad Med [serial online] 2008 [cited 2022 Jan 28 ];54:91-97
Available from: https://www.jpgmonline.com/text.asp?2008/54/2/91/40773
Obsessive compulsive disorder (OCD) is a chronic psychiatric disorder and it is one of the 10 most disabling medical conditions worldwide.  The lifetime prevalence of OCD is estimated to be around 2.5% to 3.29%. ,,, The findings of such high rates of OCD in epidemiological studies resulted in OCD being labeled as a "hidden epidemic".  It is twice as prevalent as schizophrenia and bipolar disorder and the fourth most common psychiatric disorder.  Above all, 50-60% of the OCD patients also experience two or more comorbid psychiatric conditions during their lifetime.  However, OCD has not received due attention of the clinicians, researchers and policymakers because it is a non-psychotic illness.
Available evidence indicates that OCD patients report general impairment in their functioning and report poor quality of life (QoL). ,,,, They also suffer from disability in several areas, particularly in marital, occupational, emotional and social functioning. ,,, More severe OCD symptoms were associated with general impairment in functioning.  There is evidence that even the treatment responders continue to experience poor QoL. , There are studies comparing the QoL of OCD patients with various control groups like diabetes, depression, anxiety disorders and schizophrenia, which depicted that OCD patients were either similar or had substantial impairment in QoL compared to the control groups. ,,,, In a few studies, impairment in social and family relationships and occupational functioning in OCD patients was comparable to those with schizophrenic illness. , Unfortunately, these studies did not match the comparative group for severity of the illness.
The families of OCD patients report considerable burden due to illness and reduce their social activities, leading to an increase in their feeling of isolation and distress. ,,,, They also report poor QoL in the domains of physical wellbeing, psychological wellbeing and social relationships.  A study done in India comparing the family burden across various anxiety disorders reported that the degree of burden was essentially comparable across all the groups.  We hypothesized that patients suffering from severe OCD may have comparable level of global functioning, family burden, QoL and disability with patients suffering from schizophrenia.
Materials and Methods
Participants: We recruited 70 consecutive subjects (OCD=35, schizophrenia=35) who met study criteria between March 2005 and March 2006 from the psychiatric services of the National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India. The participants gave informed consent and the study was carried out according to the ethical guidelines of the NIMHANS Ethics Committee. The study criteria included a) A primary diagnosis of DSM-IV OCD/schizophrenia,  b)continuous illness for the previous two years, c) Clinical Global Impression-Severity (CGI-S) score of≥4,  and d) availability of a primary care giver involved in the care of the patient for the past two years. We attempted to control for severity of the illness in both the groups by recruiting at least 'moderately ill' subjects, so that both the groups were similar with respect to severity, which may otherwise act as a confounding factor. The CGI severity scale requires the clinician to rate the severity of the patient's illness on a seven-point scale in which, 1 is normal (not at all ill); 2 is borderline mentally ill; 3 is mildly ill; 4 is moderately ill; 5 is markedly ill; 6 is severely ill; and 7 is among the most extremely ill.
We did not include mildly ill OCD patients since they may not have significant impairment in functioning, QoL and disability. They are also possibly not a significant burden on the healthcare system. Hence, to include homogenous comparable OCD and schizophrenia patients in terms of severity of the illness, we attempted to control the severity of the illness using CGI-S. 
Procedure: A majority of the participants were already availing the clinical services provided at the NIMHANS hospital. At least one senior psychiatrist (teaching faculty at the institute) had already diagnosed them through unstructured clinical interview during their earlier visits. We had access to the clinical records of all the participants. The principal author administered the Mini-International Neuropsychiatry Interview (MINI)  for reconfirming the diagnosis and evaluating comorbidity and the CGI-S  to determine severity.
All the data were collected by personal direct interviews of the participants and their immediate family members (i.e. the primary care giver). The medical records were also used to collate information. The principal author trained in using the instruments performed all the evaluations. The family assessment schedule and family burden was administered to primary care givers. A senior consultant (SBM) reviewed the data obtained from all the sources.
Assessments: We used the Global Assessment of Functioning (GAF),  the World Health Organization (WHO) - Quality of Life(QoL) (BREF version),  the WHO- Disability Assessment Schedule-II(WHO-DAS-II)  and the Family Burden Schedule (FBS)  to assess global functioning, quality of life and disability. The WHO - QoL (BREF version)  is a 26-item self-administered questionnaire, which emphasizes the subjective responses of patients rather than their objective life conditions. The psychometric property is comparable to that of the full version of WHO-QoL. ,
The WHO-DAS-II  was used to assess the activity limitations and participation restriction, actually experienced by an individual can we provide some details? The FBS  is a semi-structured interview schedule comprising 24 items grouped under six areas: financial burden, disruption of family routine activities, disruption of family leisure, disruption of family interaction, effect on the physical health and effect on the mental health of others. Each item is rated on a three-point scale; '0' representing no burden, '1' representing moderate burden and '2' representing severe burden.
In OCD subjects, the Yale-Brown Obsessive Compulsive Scale (YBOCS) symptom checklist and severity rating scale , and the tic disorder section of the Schedule for Tourette and Behavioral Syndromes  were employed to assess obsessive-compulsive symptoms and tics respectively. To assess the family's accommodations to the obsessive-compulsive symptoms of the patient, the Family Accommodation Scale (FAS)  was used. We used the Positive and Negative Symptom Scale (PANSS)  to assess the severity of schizophrenia symptoms.
Statistical analysis: Statistical analysis was performed using the Statistical Package for Social Sciences (SPSS) version 13.0. The SPSS syntax editor was used to recode and compute the raw scores of WHO-QoL and WHO-DAS as per the formula provided by the respective scales for final analysis. We compared categorical variables using the Fisher's exact/chi-square tests and continuous variables using the independent sample t test. For comparison of family burden, quality of life and disability between the groups, we employed Analysis of Covariance (ANCOVA) with age of onset and duration of illness as covariates. Correlation between socio-demographic/clinical variables, family accommodation and functioning with family burden, quality of life and disability was performed using the Pearson's correlation. All P values were two-tailed and statistical significance was set at PSocio-demographic and clinical variables: The socio-demographic profile of the sample is given in [Table 1]. The two groups did not differ with regards to age, gender, marital status, domicile, family income, number of years of education and family history of psychiatric illness in the first degree relatives. The OCD subjects had significantly earlier age of onset (18.36±7.8 vs. 22.23±6.7 years, t =-2.220, P =0.030), longer duration of illness (118.80±61.6 vs. 85.14±58.2 months, t = 2.350, P = 0.022), longer duration of untreated illness (43.09±50.8 vs. 17.91±25.6 months, t = 2.615, P = 0.012) and better global functioning (34.92±8.8 vs. 27.12±5.7, t = 4.367, P = t =1.7, P =0.094), although the difference was not statistically significant.
Family burden: Among the six dimensions of the family burden schedule [Table 3], schizophrenia patients had significantly higher score on financial burden (5.55±3.7 vs. 8.61± 4.9, F=8.151, P =0.006) and disruption of routine family activities (6.83±2.7 vs. 8.69±2.4, F=6.729, P =0.012). However, the two groups were similar on the other four dimensions i.e. family leisure and effect on physical and mental health of others and disruption of family interaction. Overall, family burden was significantly higher in schizophrenia patients compared to those with OCD (28.63±10.4 vs. 37.75±11.2, F= 9.029 P =0.004).
Quality of life: On the WHO QoL (BREF) scale, patients with OCD had better QOL in the physical (51.84±19.9vs. 42.76±10.1, F= 5.087, P =0.027) and environmental domains (59.74±12.2 vs. 51.88±11.9, F= 9.919, P =0.002), but they were comparable to schizophrenia patients with respect to the psychological and social domains [Table 3].
Disability: On the WHO-DAS II, patients with OCD and schizophrenia had comparable disability in all domains except in "getting along with people" (47.86±27.6 vs. 65.95±29.8, F= 5.757, P =0.019). However, the total disability score was not significantly different between both the groups (46.43±13.7vs. 51.81±17.9, F= 1.544, P =0.218).
Correlation of variables in OCD patients: Pearson's correlation of various socio-demographic and clinical variables (age of onset, duration of illness, duration of untreated illness, YBOCS severity score, CGI severity, global functioning and family accommodation) with total DAS, four domains of QOL and overall family burden score in OCD patients was carried out. Only significant findings are shown in [Table 4]. Total YBOCS scores ( r =0.441, P =0.008) and CGI-S scores ( r =0.359, P =0.034) had significant positive correlation with total disability scores. However, psychological quality of life hadsignificant negative correlation with total YBOCS scores ( r =-0.363, P =0.032) and CGI-S scores ( r =-0.459, P =0.006). Total family accommodation scores had significant positive correlation with total family burden ( r =0.479, P =0.004) but negative correlation with global assessment of functioning ( r =-0.463, P =0.005). Global assessment of functioning had significant positive correlation with social quality of life ( r =0.405, P =0.016).
We assessed the impact of comorbidity on family burden, QoL and disability in OCD. The OCD subjects without any comorbidity had significantly higher psychological quality of life compared to those with any comorbidity (44.9±11.4 vs. 32.4±14.7, t = 2.317, P =.027). Similarly, those without comorbid depression had significantly higher psychological quality of life than those without depression (43.6±14.1 vs. 28.0±11.3, t = 3.617, P =0.001). Presence of any comorbid condition and depression had no impact on family burden, disability and other domains of QoL.
To the best of our knowledge, this is the first systematic study from India to analyze and compare the family burden, quality of life and disability between patients suffering from OCD and schizophrenia after controlling for severity of the illness. The main strengths of our study include systematic and elaborate assessment of clinical profile using valid instruments.
Global functioning: The OCD subjects had major impairment in several areas of functioning such as work, social and family relationships (GAF mean score 34.92) although schizophrenia subjects were much worse (mean score 27.12) [Table 3]. Our finding is similar to the poor global functioning reported in a recent study of severely ill OCD patients admitted for intensive residential treatment.  However, other studies also report impairment in the marital and employment status of OCD-affected individuals. ,,
Family burden: In the present study, primary care givers of OCD patients reported similar family burden as primary care givers of schizophrenia with regard to disruption of family leisure, family interaction and effect on physical and mental health of others [Table 3].  However, the financial burden, disruption of family routines and overall family burden was significantly lesser in primary care givers of OCD patients than in those of schizophrenia patients. A study from India reported that the greatest burden was felt for disruption in family routine and leisure activities, with lesser burden also being felt on family interaction and financial matters.  In the study by Magliano et al. the degree of family burden correlated with the level of patients' disability and severity of patients' obsessive-compulsive symptomatology.  In contrast, our study did not show any correlation between family burden and severity of OCD and patients' disability. This is possibly because our sample constituted mainly severely ill OCD subjects as reflected in the YBOCS score [Table 2]. In a study involving narrative interviews of relatives of OCD patients, relatives described different family burdens and different coping strategies.  A recent study also reported poor health-related QoL in first-degree relatives of OCD patients. 
Family accommodation: Family accommodation of patients with OCD by participating in symptoms (proxy compulsions, compulsive reassurance, assisting in rituals and compulsions) and by modification of personal and family routines is intended to reduce the patient's anxiety or anger directed at family members.  Our study had a mean total score of 29.72 on FAS, which is an extreme family accommodation. The FAS score correlated positively with family burden, a finding similar to that of Calvocoressi et al. ,  but negatively with GAF score, which confirms the finding of a previous study  that higher accommodation is associated with lower functioning in OCD patients.
Quality of life: The OCD patients in this study reported similar QoL as schizophrenia patients in the areas of psychological and social domains. A study by Bystritsky et al. , has reported similar finding with regard to social impairment being similar in OCD and schizophrenia patients.  In the present study, patients with OCD had better physical and environmental quality of life than those with schizophrenia. Similar results have been documented in an another study, in which OCD patients reported the same QoL as schizophrenia patients in the area of mental health, but better quality of life in the areas of physical health.  Psychological QoL in OCD patients negatively correlated with severity of obsessions, total score of the YBOCS and global severity of the illness [Table 4]. In addition, those without depression had better psychological QoL. Results from the present study support those from prior investigations on quality of life in OCD. ,,, Poor psychological and social QoL in OCD could be due to the associated anxiety/distress; interference in functioning, time spent on symptoms and preserved insight into their illness.
Disability: The OCD patients and schizophrenic patients did not differ much with respect to disability on DAS except in the domain of getting around with people [Table 3]. This indicates that severe OCD produces disability often comparable to that in schizophrenia, a finding similar to those reported in two previous studies. ,
The present study has demonstrated that severe OCD is associated with significant impairment in functioning and severe family burden and disability. In addition, the QoL is poor. Families of severe OCD patients often cope with illness with high accommodation that has not been associated with good outcome. What is more alarming is that severe OCD and schizophrenia are often associated with comparable disability, family burden and poor QoL.
Our study has certain limitations that need to be kept in mind while interpreting the findings. They are: small sample size; cross-sectional evaluation; and unblended status of the rater to the diagnosis. Our inclusion criterion was recruitment of patients who were at least moderately ill on CGI-S. Therefore, the findings may not be generalizeable to a larger population of mildly ill OCD patients.
Although OCD is more prevalent than schizophrenia and the fourth most common mental disorder  with a prevalence rate of 1-3%, ,,, it has received only modest attention. Patients suffering from OCD are often undiagnosed and untreated for several years. In view of the disability, family burden and poor QoL, there is an urgent need to sensitize the healthcare professionals in recognizing and treating OCD effectively. In addition, there is a need to hasten the process of understanding the biology and treatment of OCD in view of the fact that existing treatment options are often unsatisfactory with a response rate of only 40-60%.  Lastly, efforts need to be made in the direction of educating the public about the highly prevalent nature of this illness, its common clinical manifestations and treatment options.
Authors thank Dr. Maria Christine Nirmala for her valuable comments and suggestions on the manuscript.
|1||Murray CL, Lopez AD. The global burden of disease: A comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected. Harvard University Press: Cambridge, Mass; 1996.|
|2||Weissman MM, Bland RC, Canino GJ, Greenwald S, Hwu HG, LeeCK, et al. The cross-national epidemiology of obsessive compulsive disorder. J Clin Psychiatry 1994;55:5-10.|
|3||Karno M, Golding JM, Sorenson SB, Burnam MA. The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry 1988;45:1094-9.|
|4||Robins LN, Helzer JE, Weissman MM, Orvaschel H, Gruenberg E, Burke JD Jr, et al. Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry 1984;41:949-58.|
|5||Robins LN, Helzer JE, Croughan J, Ratcliff KS. The national institute of mental health diagnostic interview schedule: Its history, characteristics and validity. Arch Gen Psychiatry 1981;38:381-9.|
|6||Hollander E. Obsessive-compulsive disorder: The hidden epidemic. J Clin Psychiatry 1997;58:3-6.|
|7||Pigott TA, L'Heureux F, Dubbert B, Bernstein S, Murphy DL. Obsessive compulsive disorder:comorbid conditions. J Clin Psychiatry 1994;55:15-27.|
|8||Moritz S, Rufer M, Fricke S, Karow A, Morfeld M, Jelinek L, et al. Quality of life in obsessive-compulsive disorder before and after treatment. Compr Psychiatry 2005;46:453-9.|
|9||Masellis M, Rector NA, Richter MA. Quality of life in OCD: Differential impact of obsessions, compulsions and depression comorbidity. Can J Psychiatry 2003;48:72-7.|
|10||Lochner C, Mogotsi M, du Toit PL, Kaminer D, Niehaus DJ, SteinDJ. Quality of life in anxiety disorders: A comparison of obsessive-compulsive disorder, social anxiety disorder and panic disorder. Psychopathology 2003;36:255-62.|
|11||Calvocoressi L, McDougle CI, Wasylink S, Goodman WK, TrufanSJ, Price LH. Inpatient treatment of patients with severe obsessive-compulsive disorder. Hosp Community Psychiatry 1993;44:1150-4.|
|12||Elizondo DM, Calamai JE, Janeck AS. Quality of life in obsessive-compulsive disorder. Paper presented at the Association for advancement of behaviour therapy. New York; 1996. p. 21-2.|
|13||Bystritsky A, Liberman RP, Hwang S, Wallace CJ, Vapnik T, MaindmentK, et al. Social functioning and quality of life comparisons between obsessive compulsive and schizophrenic disorders. Depress Anxiety 2001;14:214-8.|
|14||Steketee G. Disability and family burden in obsessive-compulsive disorder. Can J Psychiatry 1997;42:919-28.|
|15||Calvocoressi L, Lewis B, Harris M, Trufan SJ, Goodman WK, McDougle CJ, et al. Family accommodation in obsessive-compulsive disorder. Am J Psychiatry 1995;152:441-3.|
|16||Emmelkamp PM, de Haan E, Hoogduin CA. Marital adjustment and obsessive-compulsive disorder. Br J Psychiatry 1990;156:55-60.|
|17||Kim SW, Dysken MW, Kuskowski M. The Yale-brown obsessive-compulsive scale: A reliability and validity study. Psychiatr Res 1990;34:99-106.|
|18||Shetti CN, Reddy YC, Kandavel T, Kashyap K, Singisetti S, Hiremath AS, et al. Clinical predictors of drug nonresponse in obsessive-compulsive disorder. J Clin Psychiatry 2005;66:1517-23.|
|19||Koran LM, Thienemann ML, Davenport R. Quality of life for patients with obsessive-compulsive disorder. Am J Psychiatry 1996;153:783-8.|
|20||Malik ML, Connor KM, Sutherland SM, Smith RD, Davison RM, Davidson JR. Quality of life and posttraumatic stress disorder: Apilot study assessing changes in SF-36 scores before and after treatment in a placebo-controlled trial of Fluoxetine. J Trauma Stress 1999;12:387-93.|
|21||Bobes J, Gonzαlez MP, Bascarαn MT, Arango C, Sαiz PA, Bousoρo M. Quality of life and disability in patients with obsessive-compulsive disorder. Eur Psychiatry 2001;16:239-45.|
|22||Bystritsky A, Liberman RP, Hwang S, Wallace CJ, Vapnik T, MaindmentK, et al. Social functioning and quality of life comparisons between obsessive compulsive and schizophrenic disorders. Depress Anxiety 2001;14:214-8.|
|23||Black DW, Gaffney G, Schlosser S, Gabel J. The impact of obsessive-compulsive disorder on family: Preliminary findings. J Nerv Ment Dis 1998;186:440-2.|
|24||Stengler-Wenzke K, Trosbach J, Dietrich S, Angermeyer MC. Subjective burden and coping strategies of relatives of patients with OCD. J Adv Nurs 2004;48:35-42.|
|25||Renshaw KD, Chambless DL, Rodebaugh TL, Steketee G. Living with severe anxiety disorders: Relatives' distress and reactions to patient behaviours. Clin Psychol Psychother 2000;7:190-200.|
|26||Cooper M. Obsessive-compulsive disorder: Effects on family members. Am J Orthopsychiatry 1996;66:296-304.|
|27||Stengler-Wenzke K, Kroll M, Matschinger H, Angermeyer MC. Quality of life of relatives of patients with obsessive-compulsive disorder. Compr Psychiatry 2006;47:523-7.|
|28||Chakrabarti S, Kulhara P, Verma SK. The pattern of burden in families of neurotic patients. Soc Psychiatry Psychiatr Epidemiol 1993;28:172-7.|
|29||American Psychiatric Association. Diagnostic criteria from DSM-IV. American Psychiatric Association: Washington (DC); 1994.|
|30||Guy Y. ECDEU Assessment manual for psychopharmacology. U.S Department of Health, Education and Welfare, DHEW publication (ADM) 76-338; National Institute of Mental Health: Rockville, Md; 1976. p. 218-22.|
|31||Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, WeillerE. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59:22-33.|
|32||WHOQOL Group. Development of the World Health Organization WHOQOL-BREF Quality of life assessment. Psychol Med 1998;28:551-8.|
|33||World Health Organization. WHO Psychiatric disability assessment schedule (WHO/DAS) with a guide to its use. World Health Organization: Geneva; 1988.|
|34||Pai S, Kapur RL. The burden on the family of a psychiatric patient:development of an assessment scale. Br J Psychiatry 1981;38:332-5.|
|35||Orley J, Saxena S, Herrman H. Quality of life and mental illness: Reflections from the perspective of the WHOQOL. Br J Psychiatry 1998;172:291-3.|
|36||Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado PL, Heninger GR, et al. The Yale-Brown Obsessive Compulsive Scale:II, Validity. Arch Gen Psychiatry 1989a;46:1012-6.|
|37||Goodman WK, Price LH, Rasmussen SA, Mazure C, FleischmanRL, Hill CL, et al. The Yale-Brown Obsessive Compulsive Scale: I, Development, use and reliability. Arch Gen Psychiatry 1989b;46:1006-11.|
|38||Paul DL, Hurst CR. Schedule for tourette and behavioral syndromes: Adult version A3. Yale Family Genetic Study of Tourette Syndrome. Yale Child Study Center: New Haven, Connecticut; 1996.|
|39||Calvocoressi L, Mazure CM, Kasl SV, Skolnick J, Fisk D, Vegso SJ, et al. Family accommodation of obsessive-compulsive symptoms: Instrument, development and assessment of family behaviour. J Nerv Ment Dis 1999;187:636-42.|
|40||Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-7.|
|41||Stewart SE, Yen CH, Stack DE, Jenike MA. Outcome predictors for severe obsessive-compulsive patients in intensive residential treatment. J Psychiatr Res 2006;40:511-9.|
|42||Stewart SE, Stack DE, Farrell C, Pauls DL Jenike MA. Effectiveness of intensive residential treatment (IRT) for severe refractory obsessive-compulsive disorder. J Psychiatr Res 2005;39:603-9.|
|43||Magliano L, Tosini P, Guarneri M, Marasco C, Catapano F. Burden on the families of patients with obsessive-compulsive disorder: A pilot study. Eur Psychiatry 1996;11:192-7.|
|44||Stengler-Wenzke K, Trosbach J, Dietrich S, Angermeyer MC. Coping strategies used by the relatives of people with obsessive-compulsive disorder. J Adv Nurs 2004;48:35-42.|
|45||Albert U, Salvi V, Saracco P, Bogetto F, Maina G. Health-related quality of life among first-degree relatives of patients with obsessive-compulsive disorder in Italy. Psychiatr Serv 2007;58:970-6.|
|46||Math SB, Janardhan Reddy YC. Issues in the pharmacological treatment of obsessive-compulsive disorder. Int J Clin Pract 2007;61:1188-97.|